Search clinical trials for: KPT-330
Total 321 results
-
Karyopharm Therapeutics IncCompletedSolid TumorUnited States, Denmark, Canada
-
Asociación Europea y Latinoamericana SELNET para...RecruitingSarcoma,Soft TissueSpain
-
National Cancer Institute (NCI)SuspendedRecurrent Glioblastoma, IDH-Wildtype | MGMT-Methylated Glioblastoma | Recurrent MGMT-Methylated GlioblastomaUnited States
-
National Cancer Institute (NCI)RecruitingGlioblastoma | Gliosarcoma | Newly DiagnosedUnited States
-
Karyopharm Therapeutics IncCompletedMultiple MyelomaUnited States, Belgium, Austria, France, Germany, Greece
-
National Cancer Centre, SingaporeCompletedPeripheral T-cell LymphomaSingapore
-
University of Texas Southwestern Medical CenterKaryopharm Therapeutics IncCompletedNon-small Cell Lung CancerUnited States
-
Karyopharm Therapeutics IncActive, not recruitingLocally Advanced Unresectable or Metastatic MelanomaUnited States
-
Matthew InghamTakeda; Karyopharm Therapeutics IncWithdrawnSarcoma | Ewing Sarcoma | Liposarcoma | Alveolar Soft Part Sarcoma | Malignant Peripheral Nerve Sheath TumorsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Karyopharm Therapeutics IncCompletedAcute Myeloid Leukemia | LeukemiaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteTerminatedGastric Cancer | Esophageal CancerUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics IncCompletedAcute Myeloid Leukemia | Leukemia | AMLUnited States
-
Karyopharm Therapeutics IncRecruiting
-
Martin GutierrezHackensack Meridian Health; Karyopharm Therapeutics IncWithdrawn
-
National Cancer Institute (NCI)RecruitingMetastatic Alveolar Soft Part Sarcoma | Unresectable Alveolar Soft Part Sarcoma | Advanced Soft Tissue Sarcoma | Advanced Alveolar Soft Part SarcomaUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)RecruitingUntreated Adult Acute Myeloid LeukemiaUnited States
-
Saint Thomas Hospital, PanamaNot yet recruitingGestational Hypertension
-
Karyopharm Therapeutics IncSuspendedRelapsed or Refractory Diffuse Large B-Cell LymphomaUnited States
-
Gulhane School of MedicineCompletedWe Investigated the Relationship Between Plasma FGF23 Levels and Endothelial Dysfunction in a Sizable Series of Incident Stage 3-4 CKD Patients.Turkey
-
Karyopharm Therapeutics IncRecruitingOther Solid Tumors | Colorectal Cancer (CRC) | Non-Small Cell Lung Carcinoma (NSCLC)Israel
-
Chong Kun Dang PharmaceuticalCompletedHypertension | HyperlipidemiasKorea, Republic of
-
Sheba Medical CenterKaryopharm Therapeutics IncUnknown
-
Seoul National University Bundang HospitalCompletedPrimary Spontaneous PneumothoraxKorea, Republic of
-
Karyopharm Therapeutics IncTerminated
-
Karyopharm Therapeutics IncTerminatedGlioblastoma MultiformeUnited States, Canada
-
Chong Kun Dang PharmaceuticalCompletedHypertensive Patients With DyslipidemiaKorea, Republic of
-
National Cancer Institute (NCI)Recruiting
-
Karyopharm Therapeutics IncNot yet recruitingMyelofibrosis | Moderate Thrombocytopenia
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
University Health Network, TorontoActive, not recruitingSalivary Gland Cancer | Metastatic | Recurrent | AdvancedCanada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Renal Cell Carcinoma | Metastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Metastatic Melanoma | Fallopian Tube Carcinoma | Advanced Malignant Solid Neoplasm | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage III Renal... and other conditionsUnited States
-
The Lymphoma Academic Research OrganisationKaryopharm Therapeutics IncCompleted
-
Chugai Pharma TaiwanCompletedHemodialysis | Hyperphosphatemia | Cardiovascular Events
-
Universitätsklinikum Hamburg-EppendorfRecruiting
-
Karyopharm Therapeutics IncTerminated
-
Chong Kun Dang PharmaceuticalCompleted
-
Washington University School of MedicineKaryopharm Therapeutics IncRecruitingMultiple Myeloma | Myeloma-Associated AmyloidosisUnited States
-
European Myeloma NetworkKaryopharm Therapeutics IncRecruitingMultiple MyelomaSpain, United States, Germany, Netherlands, Greece, France, Italy
-
St. Jude Children's Research HospitalAbbVie; Gateway for Cancer Research; Karyopharm Therapeutics IncRecruitingRefractory Acute Myeloid Leukemia | Acute Myeloid Leukemia, in Relapse | Acute Leukemia of Ambiguous Lineage in Relapse | Refractory Acute Leukemia of Ambiguous LineageUnited States
-
OncotherapeuticsKaryopharm Therapeutics IncRecruitingRefractory Multiple MyelomaUnited States
-
St. Jude Children's Research HospitalKaryopharm Therapeutics IncTerminatedAcute Myeloid Leukemia (AML)United States
-
University of ChicagoNational Cancer Institute (NCI)CompletedAcute Myeloid LeukemiaUnited States
-
Chong Kun Dang PharmaceuticalCompleted
-
Karyopharm Therapeutics IncActive, not recruitingMyelofibrosisSpain, China, Poland, United States, France, Greece, Italy
-
AmgenTerminatedMyelodysplastic Syndrome | Relapsed/Refractory AML | Minimal Residual Disease Positive AMLUnited States, Canada, Germany, Netherlands
-
Shanxi Bethune HospitalAntengene CorporationRecruitingRelapsed or Refractory Acute Myeloid LeukemiaChina
-
Karyopharm Therapeutics IncBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States, Canada
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics IncCompletedMultiple MyelomaUnited States
-
GSO Global Clinical Research BVKaryopharm Therapeutics IncTerminatedColorectal NeoplasmGermany, Belgium